Upper tract microbiome modifications after lung transplantation and its impact in chronic lung allograft dysfunction
V. Ruiz (Barcelona, Spain), O. Khannous (Barcelona, Spain), C. Berastegui (Barcelona, Spain), K. Loor (Barcelona, Spain), M. Culebras (Barcelona, Spain), M. Deu (Barcelona, Spain), C. Mannichanh (Barcelona, Spain), A. Santiago (Barcelona, Spain), B. Saez-Gimenez (Barcelona, Spain), S. Gomez-Olles (Barcelona, Spain), E. Varela (Barcelona, Spain), M. Lopez-Meseguer (Barcelona, Spain), E. Revilla-Lopez (Barcelona, Spain), V. Monforte (Barcelona, Spain), A. Roman (Barcelona, Spain), T. Gabaldon (Barcelona, Spain)
Source: International Congress 2022 – Lung allograft dysfunction: towards better monitoring and treatment
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Ruiz (Barcelona, Spain), O. Khannous (Barcelona, Spain), C. Berastegui (Barcelona, Spain), K. Loor (Barcelona, Spain), M. Culebras (Barcelona, Spain), M. Deu (Barcelona, Spain), C. Mannichanh (Barcelona, Spain), A. Santiago (Barcelona, Spain), B. Saez-Gimenez (Barcelona, Spain), S. Gomez-Olles (Barcelona, Spain), E. Varela (Barcelona, Spain), M. Lopez-Meseguer (Barcelona, Spain), E. Revilla-Lopez (Barcelona, Spain), V. Monforte (Barcelona, Spain), A. Roman (Barcelona, Spain), T. Gabaldon (Barcelona, Spain). Upper tract microbiome modifications after lung transplantation and its impact in chronic lung allograft dysfunction. 689
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|